Skip to main content

Dopamine D2 receptor imaging inGilles de la Tourette syndrome

Buy Article:

$51.00 plus tax (Refund Policy)


Objectives– to examine postsynaptic dopamine D2 receptors in Tourette syndrome (TS). Material and methods– Seventeen patients and a control group were investigated using single photon emission computed tomography (SPECT) and iodobenzamide (123I‐IBZM). Results– In neuroleptic treated patients (n=7) 123I‐IBZM‐binding was significantly reduced compared to both normal controls (P<0.0001) and unmedicated patients (P<0.001). In unmedicated patients (n=10) mean binding ratio did not differ from that of control group. Patients in advanced stages of the disease, however, revealed significantly reduced relative striatal binding compared to patients in the early stages (P<0.005) and normal controls (P<0.0001). Conclusion– The results lend further support to the hypothesis that the dopamine receptor is involved in TS pathology. During the natural course of the disease tics often improve in early adulthood. It is suggested that this spontaneous recovery from tics may be associated with reduced receptor binding capacity.

Keywords: Dopamine receptor; Gilles de la Tourette Syndrome; IBZM‐SPECT; Pathology; Tics

Document Type: Original Article


Affiliations: 1: Department of Nuclear Medicine, 2: Department of Neurology, 3: Department of Clinical Psychiatry and Psychotherapy, Medical School Hannover, Germany

Publication date: March 1, 2000


Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more